Treatment patterns and outcomes in patients with advanced melanoma in France

Author： Bedane Christophe Leccia Marie-Thérèse Sassolas Bruno Bregman Bruno Lebbé Céleste

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.29, Iss.10, 2013-10, pp. : 1297-1305

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment patterns in advanced melanoma: findings from a survey of European oncologists

EUROPEAN JOURNAL OF CANCER CARE (ELECTRONIC), Vol. 24, Iss. 6, 2015-11 ,pp. : 862-866

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ipilimumab before BRAF inhibitor treatment may be more beneficial than vice versa for the majority of patients with advanced melanoma

CANCER, Vol. 120, Iss. 11, 2014-06 ,pp. : 1617-1619

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Emerging Role of Cytokines in the Treatment of Advanced Melanoma

Oncology, Vol. 58, Iss. 2, 2000-02 ,pp. : 89-95

Karger

Access to resources Recommend Favorite

Systemic Treatment in Advanced Melanoma: Innovative Perspectives

Oncology Research and Treatment, Vol. 26, Iss. 3, 2003-07 ,pp. : 234-238

Karger

Access to resources Recommend Favorite

Docetaxel in Combination with Dacarbazine in Patients with Advanced Melanoma

Oncology, Vol. 63, Iss. 4, 2002-11 ,pp. : 333-337

Karger

Access to resources Recommend Favorite